Frank BurrellScientific Storytelling
Joey CohenMedication Adherence
Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
39% ORR for G100+pembrolizumab is greater than either agent alone; reaches 57% ORR in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email